News & Events

Keep up to date on AgNovos events and related news

Featured posts

News

AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study

1/11/2022

AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.

News

New Manuscript on Using AGN1 Implant Material to Treat Bone Loss Published in Peer-Reviewed Journal

11/4/2021

AgNovos Healthcare is pleased to announce the publication of a manuscript titled “AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model” in the peer-reviewed journal Bone.

News

AgNovos Healthcare Enters Exclusive Option Agreement with Asahi Kasei Pharma

9/29/2021

AgNovos Healthcare is pleased to announce an exclusive option agreement with Asahi Kasei Pharma Corporation.

News

AGN1 LOEP SV Kit Receives an Investigational Device Exemption (IDE) from the U.S. FDA

4/19/2021

AgNovos Healthcare, a developer of medical technology products leveraging regenerative medicine to treat the local effects of bone disease, announced today that its newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) kit has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration.

All Articles

AgNovos Healthcare to participate in 2022 British Orthopaedic Association Congress

9/19/2022 |

AgNovos Healthcare is pleased to participate in this year’s British Orthopaedic Association Congress (BOA) from September 20-23 in Birmingham, England.

Find out more

AgNovos Healthcare to Participate in German Osteology Congress (DVO)

9/15/2022 | Events

o AgNovos Healthcare is pleased to participate in this year’s German Osteology Congress (DVO) from September 18-20 in Baden, Germany.

Find out more

AgNovos Healthcare to Participate in ASBMR Conference

9/7/2022 | Events

AgNovos Healthcare is attending this year's ASBMR conference highlighting important research on critical topics such as the drivers and dynamics of secondary fracture risk.

Find out more

AgNovos Healthcare to Participate in Swiss Orthopaedics Congress

6/21/2022 | Events

AgNovos is pleased to participate in this year’s Swiss Orthopaedics congress (SGO) from June 22-24 in Basel, Switzerland.

Find out more

AgNovos Healthcare to Participate in German Society for Geriatric Traumatology Congress (Alterstraumatologie)

5/26/2022 | News

Find out more

2022 ESCEO-AgNovos Young Investigator Award

4/4/2022 | News

It is with great pleasure that AgNovos Healthcare announces the recipients of this year’s ESCEO-AgNovos Young Investigator Award presented at World Congress on Osteoporosis in March 2022.

Find out more